IDEA #55BOKL
ICAM1 as a triple negative breast cancer biomarker and therapeutic target. ASSIGNED TO Children's Medical Center Corporation, Boston, MA, 20200106.
For more information or to license this innovation:
Log In
to view the innovation's details
Sign Up
with discount code "ECOS"
